XOMA Royalty Corporation 8.625% Series A Cumulative Perpetual Preferred Stock
XOMAPDividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| July 14, 2026 | $0.54 | 2026-07-02 | 2026-07-02 |
| April 15, 2026 | $0.54 | 2026-04-02 | 2026-04-02 |
| January 15, 2026 | $0.54 | 2026-01-02 | 2026-01-02 |
| October 15, 2025 | $0.54 | 2025-10-03 | 2025-10-03 |
| July 15, 2025 | $0.54 | 2025-07-03 | 2025-07-03 |
Dividends Summary
- Consistent Payer: XOMA Royalty Corporation 8.625% Series A Cumulative Perpetual Preferred Stock has rewarded shareholders with 22 dividend payments over the past 5 years.
- Total Returned Value: Investors who held XOMAP shares during this period received a total of $12.04 per share in dividend income.
- Latest Payout: The most recent dividend of $0.54/share was paid 4 days ago, on July 14, 2026.
- Yield & Schedule: XOMAP currently pays dividends quarterly with an annual yield of 8.64%.
- Dividend Growth: Since 2021, the dividend payout has decreased by 25.0%, from $0.72 to $0.54.
- Dividend Reliability: XOMAP has maintained or increased its dividend for 21 consecutive payments.
Company News
XOMA Royalty Corporation announced quarterly preferred stock dividends for Series A and Series B preferred shareholders, with Series A receiving $0.53906 per share and Series B receiving $0.52344 per depositary share, payable on July 15, 2026. The company also announced the redemption of all outstanding preferred stock at $25.00 per share on July...
Brodsky & Smith law firm announced investigations into four merger transactions, examining whether company boards breached fiduciary duties by failing to conduct fair processes and pay fair value to shareholders. The investigations involve Veris Residential ($19.00/share), XOMA Royalty ($39.00/share), Organon ($14.00/share), and RE/MAX Holdings (...
Halper Sadeh LLC, an investor rights law firm, is investigating four companies for potential securities law violations and breaches of fiduciary duties related to proposed mergers and acquisitions. The firm is examining whether shareholders are receiving fair consideration and whether insider benefits may be prioritized over ordinary shareholder ...
The Schall Law Firm is investigating potential breaches of fiduciary duty by XOMA Royalty Corporation's board and management regarding the company's $739 million acquisition by Ligand Pharmaceuticals. Shareholders are invited to participate in the investigation.
Investor rights law firm Halper Sadeh LLC is investigating four pharmaceutical and real estate companies for potential securities law violations and breaches of fiduciary duties related to their proposed acquisitions. The firm is examining whether shareholders are receiving fair consideration and whether insider benefits may be limiting superior ...
